Published in Antimicrob Agents Chemother on July 01, 1988
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Corneal ulcers associated with daily-wear and extended-wear contact lenses. Am J Ophthalmol (1986) 1.64
Pseudomonas corneoscleritis. Am J Ophthalmol (1987) 1.08
Topical vs subconjunctival treatment of bacterial corneal ulcers. Ophthalmology (1983) 1.01
Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc (1981) 1.00
Permeability of the cornea to topically applied drugs. Arch Ophthalmol (1974) 0.98
Ocular penetration of topically applied gentamicin. Arch Ophthalmol (1975) 0.97
Comparison of therapeutic routes in experimental Pseudomonas keratitis. Am J Ophthalmol (1979) 0.92
Therapy for ocular bacterial infection. Trans Ophthalmol Soc U K (1986) 0.91
Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am J Ophthalmol (1977) 0.90
Acute bacterial infection of the eye: bacterial keratitis and endophthalmitis. Trans Ophthalmol Soc U K (1986) 0.89
Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit. Arch Ophthalmol (1988) 0.85
Gentamicin penetration in the aqueous humor of eyes with corneal ulcers. Am J Ophthalmol (1972) 0.81
Drug delivery to the eye. Pharmacol Ther (1982) 0.80
Route of antibiotic administration in bacterial keratitis. Arch Ophthalmol (1981) 0.80
The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J Virol (1988) 3.22
Mesenteric Chyladenectasis: Report of a Case. Am J Pathol (1937) 3.13
Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A (1989) 2.43
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J Virol (1994) 2.41
Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol (1988) 1.96
A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol (1996) 1.94
Effect of phorbol 12-myristate 13-acetate and its analogue 4 alpha-phorbol 12,13-didecanoate on protein phosphorylation and lysosomal enzyme release in rabbit neutrophils. J Biol Chem (1984) 1.80
Femtosecond laser versus manual dissection for top hat penetrating keratoplasty. Br J Ophthalmol (2008) 1.80
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA (1967) 1.78
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ (2013) 1.73
Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res (1987) 1.70
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun (1997) 1.69
Further properties of the diamine oxidase of pea seedlings. Biochem J (1964) 1.63
The regional distribution and cellular localization of iron in the rat brain. Neuroscience (1984) 1.62
Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos (1993) 1.61
Responses of group III and IV muscle afferents to dynamic exercise. J Appl Physiol (1985) (1997) 1.60
New procedures for purification of L-asparaginase with high yield from Escherichia coli. J Bacteriol (1968) 1.55
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther (2001) 1.52
Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology (1990) 1.51
In-vitro comparative study of a locally prepared corneal storage medium and Optisol. Can J Ophthalmol (1996) 1.50
Stages in phage R17 infection. VI. Injection of A protein and RNA into the host cell. Virology (1972) 1.45
Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun (1994) 1.45
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A (1986) 1.43
The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med (1996) 1.41
Three decades of corneal transplantation: indications and patient characteristics. Cornea (2000) 1.40
Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease. Can J Ophthalmol (1992) 1.38
Rhabdomyolysis and a "greenhouse effect". Lancet (1990) 1.38
Time-saving formats for patient care planning in outpatient surgery units. J Post Anesth Nurs (1991) 1.37
Quantitation and kinetics of induced HSV-1 ocular shedding. Curr Eye Res (1986) 1.36
Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci U S A (1985) 1.35
Adrenergically induced recurrent HSV-1 corneal epithelial lesions. Curr Eye Res (1987) 1.31
HSV-1 shedding by lontophoresis of 6-hydroxydopamine followed by topical epinephrine. Invest Ophthalmol Vis Sci (1983) 1.31
Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci (1991) 1.30
Visualization and characterization of interleukin 1 receptors in brain. J Immunol (1987) 1.30
Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J Toxicol Environ Health A (2011) 1.28
Effects of contraction and lactic acid on the discharge of group III muscle afferents in cats. J Neurophysiol (1993) 1.27
Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience (1986) 1.25
The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J Virol (1993) 1.25
Biochemical and genetic evidence for a new class of emetine-resistant Chinese hamster cells with alterations in the protein biosynthetic machinery. Somatic Cell Genet (1980) 1.25
Response to highly purified L-asparaginase during therapy of acute leukemia. Cancer Res (1969) 1.24
The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res (1990) 1.23
Perfluorodecalin corneal toxicity: five case reports. Cornea (1996) 1.23
Genetic characterization of pyridine nucleotide uptake mutants of Salmonella typhimurium. J Gen Microbiol (1985) 1.22
Dislocation of a plate-haptic silicone intraocular lens into the anterior chamber. J Cataract Refract Surg (2001) 1.21
Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol (1986) 1.21
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest Ophthalmol Vis Sci (1996) 1.20
Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J (1992) 1.20
Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models. Neurosci Lett (2010) 1.19
Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest Ophthalmol Vis Sci (1985) 1.18
Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res (2001) 1.17
An analysis of air transport results in the sick newborn II. Antenatal and neonatal referrals. Am J Obstet Gynecol (1977) 1.16
Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem (1998) 1.14
Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Anal Biochem (2001) 1.13
Cyclooxygenase blockade attenuates responses of group IV muscle afferents to static contraction. Am J Physiol (1990) 1.12
Responses of group III and IV muscle afferents to distension of the peripheral vascular bed. J Appl Physiol (1985) (1999) 1.12
Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma. Cytotherapy (2006) 1.11
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci (1992) 1.11
Firefighters' hearing: a comparison with population databases from the International Standards Organization. J Occup Environ Med (2001) 1.11
Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci (2000) 1.10
Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases. Cancer Chemother Rep (1976) 1.09
Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. Eur J Pharmacol (1987) 1.09
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res (1995) 1.08
Unusual arsenate poisoning of the F pili of Escherichia coli. J Bacteriol (1973) 1.07
Suppression of skin hypersensitivity and antibody formation by L-asparaginase. J Immunol (1970) 1.07
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol (1994) 1.06
Human antibody to influenza C virus: its age-related distribution and distinction from receptor analogs. Infect Immun (1980) 1.06
Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology (1988) 1.06
Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest Ophthalmol Vis Sci (1981) 1.05
Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet (1994) 1.04
Ribonucleic acid labelling and nucleotide pools during compensatory renal hypertrophy. Biochem J (1974) 1.04
Clinical outcomes following penetrating keratoplasty using the Barron-Hessburg and Hanna corneal trephination systems. Cornea (1996) 1.04
Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience (1993) 1.04
Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature (1993) 1.03
Corneal wound malapposition after penetrating keratoplasty: an optical coherence tomography study. Br J Ophthalmol (2008) 1.02
Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis (1997) 1.02
Synthesis and structure determination by NMR of a putative vacuolar targeting peptide and model of a proteinase inhibitor from Nicotiana alata. Biochemistry (1996) 1.02
Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos (1993) 1.01
FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ (2006) 1.00
Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos (1989) 1.00
Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res (1992) 1.00
Properties of influenza C virus grown in cell culture. J Virol (1977) 1.00
Primary localized conjunctival amyloidosis presenting with recurrence of subconjunctival hemorrhage. Am J Ophthalmol (2000) 1.00
Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1. Invest Ophthalmol Vis Sci (1990) 0.99
Fibrin glue versus sutures for attaching the conjunctival autograft in pterygium surgery: a prospective observer masked clinical trial. Br J Ophthalmol (2008) 0.99
Biotransformation products of 3,4,4'-trichlorocarbanilide in rat, monkey, and man. Drug Metab Dispos (1978) 0.99
Identification and characterization of a third complementation group of emetine-resistant Chinese hamster cell mutants. Mol Cell Biol (1981) 0.98
Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int J Dev Neurosci (1995) 0.98
Herpes simplex virus genome replication and transcription during induced reactivation in the rabbit eye. J Virol (1997) 0.97
Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest Ophthalmol Vis Sci (2001) 0.97
T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection. Invest Ophthalmol Vis Sci (1988) 0.97
Stress-associated immunomodulation and herpes simplex virus infections. Med Hypotheses (2001) 0.96
Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci (1998) 0.96